丘脑底核深部脑刺激对帕金森病患者焦虑和抑郁的治疗效果

IF 3.1 4区医学 Q2 CLINICAL NEUROLOGY Journal of Neurorestoratology Pub Date : 2022-03-05 DOI:10.26599/JNR.2022.9040004

Zhang Feng , Wang Feng , Li Cong-Hui , Wang Ji-Wei , Han Chun-Lei , Fan Shi-Ying , Jing Shan-Quan , Jin Hong-Bo , Du Lei , Liu Wei , Wang Zi-Feng , Yin Ze-Yu , Gao Dong-Mei , Xing Yu-Jing , Yang Chen , Zhang Jian-Guo , Meng Fan-Gang

{"title":"丘脑底核深部脑刺激对帕金森病患者焦虑和抑郁的治疗效果","authors":"Zhang Feng , Wang Feng , Li Cong-Hui , Wang Ji-Wei , Han Chun-Lei , Fan Shi-Ying , Jing Shan-Quan , Jin Hong-Bo , Du Lei , Liu Wei , Wang Zi-Feng , Yin Ze-Yu , Gao Dong-Mei , Xing Yu-Jing , Yang Chen , Zhang Jian-Guo , Meng Fan-Gang","doi":"10.26599/JNR.2022.9040004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective:</h3><p>This study aimed to determine the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety and depression in Parkinson's disease (PD) patients.</p></div><div><h3>Methods:</h3><p>The clinical data of 57 patients with PD who underwent bilateral STN-DBS between March and December 2018, were retrospectively analyzed. Patient scores on the Unified Parkinson's Disease Rating Scale-Part III (UPDRS-Ⅲ), the Hamilton Anxiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), and the Parkinson's Disease Questionnaire (PDQ-39) were evaluated.</p></div><div><h3>Results:</h3><p>Patient evaluations took place preoperatively and at 1, 3, and 6-month follow-ups. The average patient improvement rates for HAM-A and HAM-D scores at the 6-month follow-up were 41.7% [interquartile range (IQR) 34.9%] and 37.5% (IQR 33.4%), respectively (both <em>p</em> < 0.001). There were positive correlations between both the rate of improvement in HAM-A scores and the rate of improvement in PDQ-39 scores (<em>r</em> = 0.538, <em>p</em> < 0.001), and between the rate of improvement in HAM-D scores and the rate of improvement in PDQ-39 scores (<em>r</em> = 0.404, <em>p</em> = 0.002) at the 6-month follow-up. HAM-A and HAM-D scores were positively correlated with the Parkinson's Hoehn-Yahr disease stage (<em>r</em> = 0.296, <em>p</em> = 0.025; and <em>r</em> = 0.380, <em>p</em> = 0.004, respectively).</p></div><div><h3>Conclusion:</h3><p>Bilateral STN-DBS can improve symptoms of anxiety and depression in PD patients.</p></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2324242622001139/pdfft?md5=cef7efd1b879670054ee818c3612a54d&pid=1-s2.0-S2324242622001139-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Therapeutic effects of subthalamic nucleus deep brain stimulation on anxiety and depression in Parkinson's disease patients\",\"authors\":\"Zhang Feng , Wang Feng , Li Cong-Hui , Wang Ji-Wei , Han Chun-Lei , Fan Shi-Ying , Jing Shan-Quan , Jin Hong-Bo , Du Lei , Liu Wei , Wang Zi-Feng , Yin Ze-Yu , Gao Dong-Mei , Xing Yu-Jing , Yang Chen , Zhang Jian-Guo , Meng Fan-Gang\",\"doi\":\"10.26599/JNR.2022.9040004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective:</h3><p>This study aimed to determine the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety and depression in Parkinson's disease (PD) patients.</p></div><div><h3>Methods:</h3><p>The clinical data of 57 patients with PD who underwent bilateral STN-DBS between March and December 2018, were retrospectively analyzed. Patient scores on the Unified Parkinson's Disease Rating Scale-Part III (UPDRS-Ⅲ), the Hamilton Anxiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), and the Parkinson's Disease Questionnaire (PDQ-39) were evaluated.</p></div><div><h3>Results:</h3><p>Patient evaluations took place preoperatively and at 1, 3, and 6-month follow-ups. The average patient improvement rates for HAM-A and HAM-D scores at the 6-month follow-up were 41.7% [interquartile range (IQR) 34.9%] and 37.5% (IQR 33.4%), respectively (both <em>p</em> < 0.001). There were positive correlations between both the rate of improvement in HAM-A scores and the rate of improvement in PDQ-39 scores (<em>r</em> = 0.538, <em>p</em> < 0.001), and between the rate of improvement in HAM-D scores and the rate of improvement in PDQ-39 scores (<em>r</em> = 0.404, <em>p</em> = 0.002) at the 6-month follow-up. HAM-A and HAM-D scores were positively correlated with the Parkinson's Hoehn-Yahr disease stage (<em>r</em> = 0.296, <em>p</em> = 0.025; and <em>r</em> = 0.380, <em>p</em> = 0.004, respectively).</p></div><div><h3>Conclusion:</h3><p>Bilateral STN-DBS can improve symptoms of anxiety and depression in PD patients.</p></div>\",\"PeriodicalId\":44709,\"journal\":{\"name\":\"Journal of Neurorestoratology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2022-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2324242622001139/pdfft?md5=cef7efd1b879670054ee818c3612a54d&pid=1-s2.0-S2324242622001139-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Neurorestoratology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2324242622001139\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurorestoratology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2324242622001139","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的:研究丘脑底核深部脑刺激(STN-DBS)对帕金森病(PD)患者焦虑和抑郁的影响。方法:回顾性分析2018年3月至12月间行双侧STN-DBS的57例PD患者的临床资料。对患者统一帕金森病评定量表第三部分(UPDRS-Ⅲ)、汉密尔顿焦虑评定量表(HAM-A)、汉密尔顿抑郁评定量表(HAM-D)和帕金森病问卷(PDQ-39)进行评分。结果:术前及随访1、3、6个月时对患者进行评估。在6个月的随访中，HAM-A和HAM-D评分的平均改善率分别为41.7%[四分位数间距(IQR) 34.9%]和37.5% (IQR 33.4%) (p <0.001)。HAM-A评分的改善率与PDQ-39评分的改善率之间存在正相关(r = 0.538, p <0.001)，以及6个月随访时HAM-D评分的改善率与PDQ-39评分的改善率之间的差异(r = 0.404, p = 0.002)。HAM-A、HAM-D评分与帕金森病分期呈正相关(r = 0.296, p = 0.025;r = 0.380, p = 0.004)。结论:双侧STN-DBS可改善PD患者的焦虑和抑郁症状。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Therapeutic effects of subthalamic nucleus deep brain stimulation on anxiety and depression in Parkinson's disease patients

Objective:

This study aimed to determine the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety and depression in Parkinson's disease (PD) patients.

Methods:

The clinical data of 57 patients with PD who underwent bilateral STN-DBS between March and December 2018, were retrospectively analyzed. Patient scores on the Unified Parkinson's Disease Rating Scale-Part III (UPDRS-Ⅲ), the Hamilton Anxiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), and the Parkinson's Disease Questionnaire (PDQ-39) were evaluated.

Results:

Patient evaluations took place preoperatively and at 1, 3, and 6-month follow-ups. The average patient improvement rates for HAM-A and HAM-D scores at the 6-month follow-up were 41.7% [interquartile range (IQR) 34.9%] and 37.5% (IQR 33.4%), respectively (both p < 0.001). There were positive correlations between both the rate of improvement in HAM-A scores and the rate of improvement in PDQ-39 scores (r = 0.538, p < 0.001), and between the rate of improvement in HAM-D scores and the rate of improvement in PDQ-39 scores (r = 0.404, p = 0.002) at the 6-month follow-up. HAM-A and HAM-D scores were positively correlated with the Parkinson's Hoehn-Yahr disease stage (r = 0.296, p = 0.025; and r = 0.380, p = 0.004, respectively).